Citigroup’s Immunocore IMCR Stock Holding History

Citigroup’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$754K	Hold	25,000	–	–	﹤0.01%	3295
2025 Q4	$868K	Sell	25,000 -49,600	-66%	-$1.75M	﹤0.01%	3222
2025 Q3	$2.71M	Sell	74,600 -30,000	-29%	-$1.02M	﹤0.01%	2416
2025 Q2	$3.28M	Buy	104,600 +49,600	+90%	+$1.54M	﹤0.01%	2254
2025 Q1	$1.63M	Buy	55,000 +30,000	+120%	+$900K	﹤0.01%	2889
2024 Q4	$738K	Hold	25,000	–	–	﹤0.01%	3581
2024 Q3	$778K	Hold	25,000	–	–	﹤0.01%	3454
2024 Q2	$847K	Buy	+25,000	New	+$1.28M	﹤0.01%	3026
2024 Q1	–	Sell	-25,000	Closed	-$1.71M	–	5741
2023 Q4	$1.71M	Buy	+25,000	New	+$1.3M	﹤0.01%	2376
2023 Q3	–	Sell	-11,000	Closed	-$660K	–	5721
2023 Q2	$660K	Buy	+11,000	New	+$628K	﹤0.01%	3162

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Citigroup's IMCR Position: Q1 2026 in Review

Citigroup reduced its Immunocore (IMCR) stake by 35% in Q1 2026, selling an estimated $77.1K and leaving 4,517 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

Citigroup first reported a position in IMCR in Q4 2022 and has held it in 14 quarters since. The position peaked at $19.9M in Q2 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Citigroup held 4,517 shares of Immunocore worth $136K as of Q1 2026.
Citigroup sold 2,383 Immunocore shares in Q1 2026, an estimated $77.1K.
Immunocore made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4167 holding.
Citigroup first reported a position in Immunocore in Q4 2022 and has held it in 14 quarters since.
Citigroup's Immunocore position peaked at $19.9M in Q2 2025.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.